Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Payables (2021 - 2025)

PAVmed (PAVM) has 5 years of Payables data on record, last reported at $342000.0 in Q3 2025.

  • For Q3 2025, Payables changed N/A year-over-year to $342000.0; the TTM value through Sep 2025 reached $342000.0, changed N/A, while the annual FY2024 figure was $657000.0, 63.21% down from the prior year.
  • Payables reached $342000.0 in Q3 2025 per PAVM's latest filing, down from $387000.0 in the prior quarter.
  • Across five years, Payables topped out at $8.2 million in Q1 2022 and bottomed at $342000.0 in Q3 2025.
  • Average Payables over 5 years is $2.4 million, with a median of $1.8 million recorded in 2023.
  • Peak YoY movement for Payables: surged 275.0% in 2022, then crashed 84.72% in 2023.
  • A 5-year view of Payables shows it stood at $3.3 million in 2021, then fell by 18.04% to $2.7 million in 2022, then plummeted by 33.95% to $1.8 million in 2023, then tumbled by 63.21% to $657000.0 in 2024, then crashed by 47.95% to $342000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Payables were $342000.0 in Q3 2025, $387000.0 in Q2 2025, and $369000.0 in Q1 2025.